Metraipolis › archive › dc_44d519f3eb53
RSV Vaccines: Targeting Prefusion F and G Proteins from Structural Design to Clinical Application — Europe PMC PMID:41295506
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41295506
- DOI
- 10.3390/vaccines13111133
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T20:04:20.687Z
- SHA-256 of the archived text
dec812a512fe3e31e3f45ce0eb4932c013085a726a8d41a4446eafd4f7b25588- Stable URL of this page
https://metraipolis.com/documento/dc_44d519f3eb53
How to cite
RSV Vaccines: Targeting Prefusion F and G Proteins from Structural Design to Clinical Application — Europe PMC PMID:41295506 — Europe PMC (en), https://europepmc.org/article/MED/41295506 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_44d519f3eb53 (Metraipolis archive dc_44d519f3eb53, sha256 dec812a512fe3e31e3f45ce0eb4932c013085a726a8d41a4446eafd4f7b25588)
BibTeX
@misc{dc44d519f3eb53,
title = {RSV Vaccines: Targeting Prefusion F and G Proteins from Structural Design to Clinical Application — Europe PMC PMID:41295506},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41295506},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_44d519f3eb53; sha256 dec812a512fe3e31e3f45ce0eb4932c013085a726a8d41a4446eafd4f7b25588},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41295506. Agents can read the archived copy with the MCP tool read_document.